The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Panitumumab in platinum-sensitive epithelial ovarian cancer patients with KRAS wild-type: The PROVE-study, a phase II randomized multicenter study of the North-Eastern German Society of Gynaecologic Oncology.
 
Radoslav Chekerov
Honoraria - AstraZeneca; Medac; Roche
Travel, Accommodations, Expenses - Medac
 
Peter Klare
No Relationships to Disclose
 
Petra Krabisch
No Relationships to Disclose
 
Jochem Potenberg
No Relationships to Disclose
 
Georg Heinrich
No Relationships to Disclose
 
Lothar Mueller
No Relationships to Disclose
 
Christian M. Kurbacher
No Relationships to Disclose
 
Eva-Maria Grischke
No Relationships to Disclose
 
Elena Ioana Braicu
Honoraria - Fujirebio Diagnostics; Roche
Travel, Accommodations, Expenses - Fujirebio Diagnostics; Roche
 
Pauline Wimberger
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - Amgen; AstraZeneca; Medac; Pharma Marathi; Roche; Tesaro
Consulting or Advisory Role - Roche
Research Funding - Amgen; Fresenius Biotech
Travel, Accommodations, Expenses - AstraZeneca; medac; Roche